Pharmacogenetics of the response to beta 2 agonist drugs: a systematic overview of the field.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Pharmacogenomics (London)

• Publication date

  2007-08-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2217/14622416.8.8.933PMID 17716228
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A common coding variant in CASP8 is associated with breast cancer risk

  2007cited by this paper
• ADRB2 Arg16Gly Polymorphism, Lung Function, and Mortality: Results from the Atherosclerosis Risk in Communities Study

  2007cited by this paper
• Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium.

  2007cited by this paper
• Comment on "A Common Genetic Variant Is Associated with Adult and Childhood Obesity"

  2007cited by this paper
• The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response

  2007cited by this paper
• Molecular evidence‐based medicine

  2007cited by this paper
• Merging and emerging cohorts: Necessary but not sufficient

  2007cited by this paper
• On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies.

  2007cited by this paper
• A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity

  2007cited by this paper
• Comment on "A Common Genetic Variant Is Associated with Adult and Childhood Obesity"

  2007cited by this paper
• Non-Replication and Inconsistency in the Genome-Wide Association Setting

  2007cited by this paper
• Comment on "A Common Genetic Variant Is Associated with Adult and Childhood Obesity"

  2007cited by this paper
• The Emergence of Networks in Human Genome Epidemiology: Challenges and Opportunities

  2007cited by this paper
• The PTGDR gene is not associated with asthma in 3 ethnically diverse populations.

  2006cited by this paper
• Delivering New Disease Genes

  2006cited by this paper
• Common genetic variants for breast cancer: 32 largely refuted candidates and larger prospects.

  2006cited by this paper
• Influence of β2-Adrenergic Receptor Genotype on Airway Function During Exercise in Healthy Adults

  2006cited by this paper
• Tachyphylaxis to beta2-agonists in Spanish asthmatic patients could be modulated by beta2-adrenoceptor gene polymorphisms.

  2006cited by this paper
• Eotaxin polymorphisms and serum total IgE levels in children with asthma.

  2006cited by this paper
• Overview of the pharmacogenetics of asthma treatment

  2006cited by this paper
• Tachyphylaxis to β2-agonists in Spanish asthmatic patients could be modulated by β2-adrenoceptor gene polymorphisms

  2006cited by this paper
• Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases.

  2006cited by this paper
• The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations.

  2006cited by this paper
• The Association between Common Vitamin D Receptor Gene Variations and Osteoporosis: A Participant-Level Meta-Analysis

  2006cited by this paper
• Genome-wide linkage analysis of pulmonary function in families of children with asthma in Costa Rica

  2006cited by this paper
• beta-Adrenergic receptor polymorphisms and response to salmeterol.

  2006cited by this paper
• Sequence, haplotype, and association analysis of ADRbeta2 in a multiethnic asthma case-control study.

  2006cited by this paper
• Concordance of functional in vitro data and epidemiological associations in complex disease genetics

  2006cited by this paper
• Limited β2-adrenoceptor haplotypes display different agonist mediated airway responses in asthmatics

  2006cited by this paper
• Beta2-adrenergic receptor polymorphisms in African American children with status asthmaticus.

  2006cited by this paper
• ADAM33 haplotypes are associated with asthma in a large Australian population

  2006cited by this paper
• The publication process itself was the major cause of publication bias in genetic epidemiology.

  2006cited by this paper
• A road map for efficient and reliable human genome epidemiology

  2006cited by this paper
• T-bet polymorphisms are associated with asthma and airway hyperresponsiveness.

  2006cited by this paper
• A Common Genetic Variant Is Associated with Adult and Childhood Obesity

  2006cited by this paper
• Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers

  2006cited by this paper
• Beta2-adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: a genetic association study.

  2006cited by this paper
• Journals Should Publish All “Null” Results and Should Sparingly Publish “Positive” Results

  2006cited by this paper
• Are We Ready for Genome-wide Association Studies?

  2006cited by this paper
• Beta 2-adrenergic receptor polymorphisms: pharmacogenetic response to bronchodilator among African American asthmatics.

  2006cited by this paper
• Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.

  2006cited by this paper
• Arginine-16 β2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol

  2006cited by this paper
• Making Sense of Puzzling Genetic Association Studies: A Team Approach

  2006cited by this paper
• Commonly studied single-nucleotide polymorphisms and breast cancer: Results from the Breast Cancer Association Consortium

  2006cited by this paper
• The SERPINE2 gene is associated with chronic obstructive pulmonary disease.

  2006cited by this paper
• An empirical evaluation of multifarious outcomes in pharmacogenetics: beta-2 adrenoceptor gene polymorphisms in asthma treatment

  2006cited by this paper
• CD14 tobacco gene-environment interaction modifies asthma severity and immunoglobulin E levels in Latinos with asthma.

  2005cited by this paper
• Association between bronchodilating response to short-acting beta-agonist and non-synonymous single-nucleotide polymorphisms of beta-adrenoceptor gene.

  2005cited by this paper
• Genome-wide association studies for common diseases and complex traits

  2005cited by this paper
• Why Most Published Research Findings Are False

  2005cited by this paper
• β2‐ADR haplotypes/polymorphisms associate with bronchodilator response and total IgE in grass allergy

  2005cited by this paper
• Genome-wide association studies: theoretical and practical concerns

  2005cited by this paper
• Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between beta-agonist and corticosteroid pathways.

  2005cited by this paper
• HUMAN GENOME EPIDEMIOLOGY (HuGE) REVIEW Systematic Review and Meta-Analysis of the Association between b 2 -Adrenoceptor Polymorphisms and Asthma: A HuGE Review

  2005cited by this paper
• Local Literature Bias in Genetic Epidemiology: An Empirical Evaluation of the Chinese Literature

  2005cited by this paper
• Bronchodilator response in relation to beta2-adrenoceptor haplotype in patients with asthma.

  2005cited by this paper
• Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations.

  2005cited by this paper
• Beta 2 adrenergic receptor polymorphisms in cystic fibrosis

  2005cited by this paper
• β2-adrenergic receptor polymorphisms and response to salbutamol among Indian asthmatics∗

  2005cited by this paper
• Contribution of ADAM33 polymorphisms to the population risk of asthma

  2005cited by this paper
• Gene–environment interactions in human diseases

  2005cited by this paper
• Selective reporting biases in cancer prognostic factor studies.

  2005cited by this paper
• Recent developments in genomewide association scans: a workshop summary and review.

  2005cited by this paper
• Extended haplotype in the tumor necrosis factor gene cluster is associated with asthma and asthma-related phenotypes.

  2005cited by this paper
• Genomewide screen for pulmonary function in 200 families ascertained for asthma.

  2005cited by this paper
• Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma.

  2005cited by this paper
• ALOX5 promoter genotype, asthma severity and LTC4 production by eosinophils

  2005cited by this paper
• Association between bronchodilating response to short‐acting β‐agonist and non‐synonymous single‐nucleotide polymorphisms of β2‐adrenoceptor gene

  2005cited by this paper
• Beta(2)-adrenergic receptor polymorphisms and response to salbutamol among Indian asthmatics*.

  2005cited by this paper
• The transforming growth factor-β1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD)

  2004cited by this paper
• Urinary leukotriene LTE4 levels in non-responders to antileukotriene therapy.

  2004cited by this paper
• Genome-wide linkage of forced mid-expiratory flow in chronic obstructive pulmonary disease.

  2004cited by this paper
• The IL12B gene is associated with asthma.

  2004cited by this paper
• Assessing the probability that a positive report is false: an approach for molecular epidemiology studies.

  2004cited by this paper
• ADAM33 polymorphisms and phenotype associations in childhood asthma.

  2004cited by this paper
• Mapping complex disease loci in whole-genome association studies

  2004cited by this paper
• IL10 gene polymorphisms are associated with asthma phenotypes in children

  2004cited by this paper
• Association of vitamin D receptor gene polymorphisms with childhood and adult asthma.

  2004cited by this paper
• Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies

  2004cited by this paper
• The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD).

  2004cited by this paper
• Cross tolerance to salbutamol occurs independently of β2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol

  2004cited by this paper
• Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial.

  2004cited by this paper
• Family-based association analysis of beta2-adrenergic receptor polymorphisms in the childhood asthma management program.

  2003cited by this paper
• Genetic associations in large versus small studies: an empirical assessment.

  2003cited by this paper
• Genetic associations: false or true?

  2003cited by this paper
• Concomitant occasional use of salbutamol influences bronchoprotective responsiveness afforded by formoterol in patients with the glycine-16 genotype

  2003cited by this paper
• ADAM33 is not associated with asthma in Puerto Rican or Mexican populations.

  2003cited by this paper
• Genome-wide linkage analysis of bronchodilator responsiveness and post-bronchodilator spirometric phenotypes in chronic obstructive pulmonary disease.

  2003cited by this paper
• Chromosome 12q harbors multiple genetic loci related to asthma and asthma-related phenotypes.

  2003cited by this paper
• Add-on therapy with montelukast or formoterol in patients with the glycine-16 beta2-receptor genotype.

  2003cited by this paper
• Polymorphisms in the β2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers

  2003cited by this paper
• The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol.

  2003cited by this paper
• Polymorphisms in toll-like receptor 4 are not associated with asthma or atopy-related phenotypes.

  2002cited by this paper
• β2 adrenoceptor gene polymorphisms in cystic fibrosis lung disease

  2002cited by this paper
• Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness

  2002cited by this paper
• beta2 adrenoceptor gene polymorphisms in cystic fibrosis lung disease.

  2002cited by this paper
• Univariate and multivariate family‐based association analysis of the IL‐13 ARG130GLN polymorphism in the Childhood Asthma Management program

  2002cited by this paper
• Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT(1) antagonist, pranlukast, in Japanese patients with moderate asthma.

  2002cited by this paper
• Replication validity of genetic association studies

  2001cited by this paper
• Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research Framework.

  2000cited by this paper

• β2-Adrenergic Signaling Promotes Higher-Affinity B Cells and Antibodies.

  2023cites this paper
• Association between F+1 polymorphism in a disintegrin and metalloprotease 33 (ADAM33) gene and chronic obstructive pulmonary disease susceptibility: An evidence-based meta-analysis.

  2019cites this paper
• Pharmacogenomics and pharmacoepigenomics in pediatric medicine.

  2014cites this paper
• Pharmacogenomics in Drug Discovery and Development

  2014cites this paper
• Common Variants near the Melanocortin 4 Receptor Gene are Associated with Severe Antipsychotic Drug-induced Weight Gain

  2014cites this paper
• NAVAGATE: a rubric to move from pharmacogenomics science to pharmacogenomics practice.

  2012cites this paper
• Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain.

  2012cites this paper
• A pharmacogenetic study of ADRB2 polymorphisms and indacaterol response in COPD patients

  2011cites this paper
• [Pharmacogenomics and the path towards personalized medicine].

  2010cites this paper
• β2‐Adrenergic Receptor Promoter Haplotype Influences Spirometric Response During an Acute Asthma Exacerbation

  2008cites this paper
• Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment

  2008cites this paper